Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Tazemetostat Pill
Locations
1
United States
Weill Cornell Medicine/NewYork-Presbyterian Hospital
New York, New York, United States
Start Date
October 4, 2023
Primary Completion Date
September 1, 2026
Completion Date
September 1, 2031
Last Updated
August 15, 2025
NCT07545603
NCT05272384
NCT06395103
NCT06149286
NCT06263491
NCT05139017
Lead Sponsor
Weill Medical College of Cornell University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions